enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Yes, the price of an inhaler in the US is massively higher ...

   www.aol.com/yes-price-inhaler-us-massively...

   One international pharmaceutical company charges $489 for brand name inhaler Combivent Respimat in the United States but just $7 in France.

3. Fact check: Yes, the price of an inhaler in the U.S. is ... - AOL

   www.aol.com/fact-check-yes-price-inhaler...

   “ Inhaler prices are low elsewhere, in part, because governments negotiate prices based on the value of the drugs compared to existing therapies.” ... Drugs.com “Combivent Respimat Prices ...

4. Bernie Sanders, Senate Democrats open investigation into ...

   www.aol.com/bernie-sanders-senate-democrats-open...

   Sanders said GSK has charged $319 for its Advair HFA product in the US, compared with $26 in the United Kingdom; that Teva charged $286 for its QVAR RediHaler in the US versus $9 in Germany; and ...

5. Ipratropium bromide/salbutamol - Wikipedia

   en.wikipedia.org/wiki/Ipratropium_bromide/salbutamol

   Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD). [ 1 ] [ 4 ] [ 5 ] It contains ipratropium (an anticholinergic ) and salbutamol (albuterol, a β 2 -adrenergic agonist ).

6. Prescription drug prices in the United States - Wikipedia

   en.wikipedia.org/wiki/Prescription_drug_prices...

   Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.

7. Health care prices in the United States - Wikipedia

   en.wikipedia.org/wiki/Health_care_prices_in_the...

   Proximate reasons for the differences with other countries include higher prices for the same services (i.e., a higher price per unit) and greater use of healthcare (i.e., more units consumed). Higher administrative costs, higher per-capita income, and less government intervention to drive down prices are deeper causes. [4]